Bone metabolism and vitamin D levels in carbamazepine-treated patients.
Verrotti
Alberto
A
Matricardi
Sara
S
Manco
Rossella
R
Chiarelli
Francesco
F
D000927:Anticonvulsants / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001846:Bone Development / Q000187:drug effects / Q000502:physiology; D001862:Bone Resorption / Q000139:chemically induced / Q000378:metabolism; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism*; D002220:Carbamazepine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D014807:Vitamin D / Q000097:blood* / Q000378:metabolism; D014808:Vitamin D Deficiency / Q000139:chemically induced / Q000378:metabolism
D000927:Anticonvulsants; D014807:Vitamin D; D002220:Carbamazepine